Skip to main content
Premium Trial:

Request an Annual Quote

New Products: EpiCypher's EpiTitan Histone Peptide Array

Premium

EpiCypher recently launched Epititan, its next-generation histone peptide array. The Chapel Hill, NC-based company said that it designed EpiTitan to support the high-throughput screening of effector protein interaction, antibody binding, and enzyme activity.

According to Epicypher, the peptides on the array encompass over 95 unique modifications in the fore core histones – H2A, H2B, H3, and H4. Each array contains more than 265 histone peptides spotted 12 times each, the firm noted.

On its website, EpiCypher is offering the arrays with a list price of $299, or $1,199 for five arrays.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.